$35 would have been the cap on copay.

Costs over that are passed on to the consumer via higher premiums.

The CalRx is $30 total.

I think insulin specifically and medicines/drugs in general might be another area that CA leads the country in modeling how to manage prices and overall cost.

So, it’s still under the $35 limit. Seems like that doesn’t answer the grandparent’s question.

It's a bill created by big pharma to whitewash their image while changing nothing about their profiteering. We should not have these sort of laws on the books.

Why put another law on the books when you believe it will be obviated by other measures?

One reason I can think of is that a law might be more politically "durable" than a contract with a third party to produce insulin. But on the whole I think I'd rather one less law.

The $35 is a cap on co-pay, not the actual cost paid out by insurance.